HERPESVIRUS-ASSOCIATED LYMPHOMAS: INVESTIGATIONS IN HUMANS AND ANIMAL MODELS

被引:1
作者
Rajcani, J. [1 ,2 ]
Asvanyi-Molnar, N. [2 ]
Szathmary, S. [3 ]
机构
[1] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia
[2] RT Europe Nonprofit Ltd, H-9200 Mosonmagyarovar, Hungary
[3] Galenbio Ltd, H-1037 Budapest, Hungary
关键词
lymphotropic gammaherpesviruses; oncogenes; lymphoma; lymphoproliferation; cell transformation; EPSTEIN-BARR-VIRUS; MAREKS-DISEASE VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; LATENT MEMBRANE-PROTEIN; REED-STERNBERG CELLS; NF-KAPPA-B; IN-SITU HYBRIDIZATION; CAVITY-BASED LYMPHOMA; HODGKINS-DISEASE; BURKITTS-LYMPHOMA;
D O I
10.1556/AMicr.57.2010.4.3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphomas are solid tumors consisting of lymphoid cells; they form a heterogeneous group of less or more malignant disorders. A portion of lymphomas develop due to latent herpesvirus infections established in B and/or T-lymphocytes. The basis for latency is a lifelong presence of the circularized covalently linked viral genome within nuclei of carrier lymphocytes. In certain cases, however, the essential event leading to tumor formation is the integration of a portion(s) of viral DNA into the host cell DNA. This leads to rearrangements within the host cell genome on one hand, and, on other hand, to unregulated expression of oncoproteins encoded by the integrated fragment. Our review deals with mechanisms of lymphoma formation regarding to the role of non-structural herpesvirus oncoproteins interfering with the regulation of cell division and/or exerting anti-apoptotic effects. In addition, the authors wish to highlight the common procedures, which allowed isolation and/or identification of lymphoma-associated viruses in cell cultures derived from tumors and/or proliferating lymphatic tissues.
引用
收藏
页码:349 / 376
页数:28
相关论文
共 146 条
  • [1] EPSTEIN-BARR VIRUS GENOMES WITH PROPERTIES OF CIRCULAR DNA-MOLECULES IN CARRIER CELLS
    ADAMS, A
    LINDAHL, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (04) : 1477 - 1481
  • [2] Herpesvirus ateles Tio can replace herpesvirus saimiri StpC and Tip oncoproteins in growth transformation of monkey and human T cells
    Albrecht, JC
    Biesinger, B
    Müller-Fleckenstein, I
    Lengenfelder, D
    Schmidt, M
    Fleckenstein, B
    Ensser, A
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (18) : 9814 - 9819
  • [3] Primary structure of the Herpesvirus ateles genome
    Albrecht, JC
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (02) : 1033 - 1037
  • [4] PRIMARY STRUCTURE OF THE HERPESVIRUS SAIMIRI GENOME
    ALBRECHT, JC
    NICHOLAS, J
    BILLER, D
    CAMERON, KR
    BIESINGER, B
    NEWMAN, C
    WITTMANN, S
    CRAXTON, MA
    COLEMAN, H
    FLECKENSTEIN, B
    HONESS, RW
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (08) : 5047 - 5058
  • [5] EPSTEIN-BARR-ENCODED RNA IN-SITU HYBRIDIZATION - DIAGNOSTIC APPLICATIONS
    AMBINDER, RF
    MANN, RB
    [J]. HUMAN PATHOLOGY, 1994, 25 (06) : 602 - 605
  • [6] Ambinder RF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P885
  • [7] Latency of Marek's Disease Virus (MDV) in a Reticuloendotheliosis Virus-Transformed T-Cell Line. II: Expression of the Latent MDV Genome
    Arumugaswami, Vaithilingaraja
    Kumar, Pankaj M.
    Konjufca, Vjollca
    Dienglewicz, Robert L.
    Reddy, Sanjay M.
    Parcells, Mark S.
    [J]. AVIAN DISEASES, 2009, 53 (02) : 156 - 165
  • [8] DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME
    BAER, R
    BANKIER, AT
    BIGGIN, MD
    DEININGER, PL
    FARRELL, PJ
    GIBSON, TJ
    HATFULL, G
    HUDSON, GS
    SATCHWELL, SC
    SEGUIN, C
    TUFFNELL, PS
    BARRELL, BG
    [J]. NATURE, 1984, 310 (5974) : 207 - 211
  • [9] A NOVEL B-CELL LINEAGE-SPECIFIC TRANSCRIPTION FACTOR PRESENT AT EARLY BUT NOT LATE STAGES OF DIFFERENTIATION
    BARBERIS, A
    WIDENHORN, K
    VITELLI, L
    BUSSLINGER, M
    [J]. GENES & DEVELOPMENT, 1990, 4 (05) : 849 - 859
  • [10] Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
    Bargou, RC
    Emmerich, F
    Krappmann, D
    Bommert, K
    Mapara, MY
    Arnold, W
    Royer, HD
    Grinstein, E
    Greiner, A
    Scheidereit, C
    Dörken, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 2961 - 2969